Advanced Bionics v MED-EL Elektromedizinische Geräte (CFI, 15 April 2024)
| Date | 15 April 2024 |
|---|---|
| Court | CFI |
| Division | Mannheim (DE) Local Division |
| Type of action | Generic application |
| Registry reference | App_12139/2024 · ORD_13321/2024 |
| Parties | Advanced Bionics GmbH, Advanced Bionics AG, Advanced Bionics Sarl |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 15 April 2024 (UPC_CFI_410/2023, ACT_12139/2024), the President of the Court of First Instance, Florence Butin, having consulted the panel of the Mannheim Local Division (Rule 323.3 RoP), refused the application by Advanced Bionics AG, Advanced Bionics GmbH and Advanced Bionics Sarl, defendants in the infringement action on EP 4 074 373 brought by MED-EL Elektromedizinische Geräte Gesellschaft m.b.H., to change the language of the proceedings from German to English. The order accepts an application lodged before the statement of defence but requires a concrete disadvantage.
Question
Is an application to change the language under Art. 49(5) UPCA admissible before the statement of defence, and have the defendants shown sufficient grounds of fairness?
Decision
The application is admissible: Rule 323 RoP sets a latest deadline, and the efficiency objective in the preamble to the Rules supports early filing. It fails on the merits. The President weighed the parties’ interests in the light of fairness. Parallel proceedings, the use of an English patent attorney and internal group practices stem from the defendants’ strategic choices and do not significantly affect the conduct of the defence. Two defendants are seated in German-speaking countries and the third is an affiliate. No financial imbalance or case-specific disadvantage was shown, and cost and inconvenience alone are not enough. Costs are reserved to the main proceedings. An appeal lies within 15 days (Art. 73(2)(a) UPCA and Rule 220.1(c) RoP).
Key points for practice
- Practical point: a language change application may be filed at the outset, but it must show a concrete disadvantage for the defence beyond cost or the group’s own organisational choices.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 41(1), Art. 49(1) to (5) and Art. 73(2)(a)
- Rules of Procedure
- Rules 23, 220.1(c), 271.7, 321.1, 322 and 323
- Case law cited
- The Hague Local Division, 18 October 2023, UPC_CFI_225/2023, Aarke v SodaStream Industries, Düsseldorf Local Division, 16 January 2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantAdvanced Bionics AG7 decisions in the corpusFollow this party
- claimantAdvanced Bionics GmbH5 decisions in the corpusFollow this party
- claimantAdvanced Bionics Sarl5 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- La demande des défenderesses tendant à faire de l'anglais la langue de procédure est recevable avant le mémoire en défense mais rejetée, faute de désavantage concret pour leur défense.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 4 074 373mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Aarke v SodaStream Industries (CFI, 16 January 2024) cited in this record
- Maxeon Solar v Aiko Energy Germany (CFI, 23 August 2024) cites this decision
- Roche Diabetes Care v Tandem Diabetes Care (CFI, 26 July 2024) cites this decision
- Advanced Bionics v MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. (CoA, ORD_42779/2024, 5 September 2024) cites this decision
Patents and standards
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.